Marketing-authorisation holder
O.P. Pharma S.R.L.
7 medicines in 2 countries, as authorisation holder and marketer.
Medicines
Every medicine in the registers under its name, current ones first.
7 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| DENOLIX 10.000 UI/ML GOTAS ORALES EN SOLUCION0,25 mg · Gotas orales en solución | Vitamin d | Spain | Marketed | 2019 |
| DENOLIX 25.000 UI/2,5 ML SOLUCION ORAL0,25 mg · Solución oral | Vitamin d | Spain | Marketed | 2019 |
| DENOLIX 50.000 UI/2,5 ML SOLUCION ORAL50.000 ui · Solución oral | Vitamin d | Spain | Authorised | 2022 |
| DISTEOMINSoluzione orale in contenitore monodose | Vitamin d | Italy | Authorised | |
| MUSCORIL DOLORE E INFIAMMAZIONEGel | Diclofenac | Italy | Authorised | |
| TRAULENCompressa a rilascio prolungato | Diclofenac | Italy | Authorised | |
| TRILONDCompressa | Candesartan cilexetil, Amlodipine, Atorvastatin | Italy | Authorised |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Italy | 4 | 4 | 0 | CompaniesAll medicines |
| Spain | 3 | 3 | 0 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Topical products for joint and muscular painMusculo-skeletal system · ATC M02A
- VitaminsAlimentary tract and metabolism · ATC A11C
- Lipid-modifying agentsCardiovascular system · ATC C10B
- Anti-inflammatory and antirheumatic productsMusculo-skeletal system · ATC M01A
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- o p
- o p pharma s r l
- o p pharma srl
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 7
- Countries
- 2
- Roles
- Authorisation holder and marketer